Quarterly report pursuant to Section 13 or 15(d)

Licensing and Other Arrangements - Rezolute (Details)

v3.22.2.2
Licensing and Other Arrangements - Rezolute (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 37 Months Ended
Dec. 06, 2017
USD ($)
Jan. 31, 2022
USD ($)
Oct. 31, 2020
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2021
USD ($)
Licensing and other arrangements                  
Revenue recognized       $ 25 $ 550 $ 3,300 $ 1,094    
Rezolute                  
Licensing and other arrangements                  
Reverse stock split     0.02            
Rezolute | License Agreement and Common Stock Purchase Agreement                  
Licensing and other arrangements                  
Revenue recognized   $ 2,000   0 $ 0 2,000 $ 0    
Payments received upon achievement of financing activities               $ 6,000  
Installment payments received               $ 8,500  
Number of shares received | shares               161,861  
Contract assets       0   0     $ 0
Contract liabilities       0   0     0
Capitalized contract costs       $ 0   $ 0     $ 0
Rezolute | License Agreement                  
Licensing and other arrangements                  
Percentage of decrease in future royalty obligations 20.00%                
Agreement termination prior written notice period 90 days                
License agreement consideration received $ 0                
Rezolute | License Agreement, RZ358                  
Licensing and other arrangements                  
Maximum eligible milestone payments receivable upon achievement of development, regulatory and commercial milestones $ 232,000                
Royalty payment period 12 years                
Rezolute | License Agreement, Non-RZ358 products                  
Licensing and other arrangements                  
Royalty payment period 12 years